Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2025 Capital Markets Day on March 27, 2025, beginning at ...

Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are impressive. Yet, a challenging international market with geopolitical pressure ...

Alcon forecast sales of between $10.2 and $10.4 billion for 2025, after the eye care group reported higher fourth-quarter revenue underpinned by its surgical division on Tuesday.

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...

Alcon operates in two segments: vision care and surgical. Vision care made up 43% of fiscal 2023 total sales and comprises contact lenses and ocular health products. The U.S. contact lens market ...

Alcon operates in two segments: vision care and surgical. Vision care is roughly 45% of total sales and comprises contact lenses and ocular health products. The U.S. contact lens market is mainly ...

CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching $9.8 billion, a 6% increase, and core diluted EPS growing by 16% to $3.05. Free cash flow hit a record $1 ...

In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the ...

Within the Surgical business ... banking on strong sales of its contact lenses and ocular health products. In contact lenses, Alcon, with its strategic investments, has secured its position ...